News

COVID-19 mRNA vaccines are highly effective in protecting people with immune-related inflammatory diseases against hospitalization and death, a new Canadian study suggests.

Our Chief Science Officer, Dr. Sian Bevan, and arthritis ambassador Darlene McPherson, comment on how COVID-19 has led to a shortage of Hydroxychloroquine – a drug used to treat Rheumatoid Arthritis and Lupus – and how it's impacting patients. The Arthritis Society continues to...